Fig. 2From: Enhanced preferential cytotoxicity through surface modification: synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231)XRD peaks of ZnO (a) and modified ZnO (b) showing peaks at 2θ values from 5° to 80° with corresponding values showing miller indices (hkl values)Back to article page